[Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy*; D004070:Digitalis / Q000627:therapeutic use; D004562:Electrocardiography; D005021:Ethylamines / Q000627:therapeutic use; D005260:Female; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009281:Naphthalenes / Q000627:therapeutic use*; D010138:Pacemaker, Artificial; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011422:Propionates / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D011422:Propionates; D014665:Vasodilator Agents
Vasodilatantien bi peripherarterieller Verschlusskrankheit mit Koronarinsuffizienz, Herzinfarkt und Herzschrittmacher. Elektrokardiographische Untersuchungen während intravenöser Naftidrofuryl-Infusion